94 related articles for article (PubMed ID: 2967486)
1. [Encephalopathy caused by an ifosfamide-mesna combination].
Beuzeboc P; Dorval T; Garcia-Giralt E; Jouve M; Livartowski A; Palangie T; Scholl S; Pouillart P
Presse Med; 1988 Apr; 17(12):591-2. PubMed ID: 2967486
[No Abstract] [Full Text] [Related]
2. Avoiding ifosfamide/mesna encephalopathy.
Meanwell CA; Kelly KA; Blackledge G
Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
[No Abstract] [Full Text] [Related]
3. Encephalopathy with rapid infusion ifosfamide/mesna.
Perren TJ; Turner RC; Smith IE
Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
[No Abstract] [Full Text] [Related]
4. Fatal encephalopathy with ifosfamide/mesna.
Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
[No Abstract] [Full Text] [Related]
5. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz JP; Hayat M
Bull Cancer; 1988; 75(4):391-2. PubMed ID: 3132998
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide, mesna, and encephalopathy.
Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
[No Abstract] [Full Text] [Related]
7. Irreversible encephalopathy with ifosfamide/mesna.
Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
[No Abstract] [Full Text] [Related]
8. Encephalopathy associated with ifosphamide/mesna therapy.
Meanwell CA; Blake AE; Latief TN; Blackledge G; Mould JJ; Blake DR; Shaw IC; Honigsberger L; Spooner D; Williams AC
Lancet; 1985 Feb; 1(8425):406-7. PubMed ID: 2857462
[No Abstract] [Full Text] [Related]
9. Ifosfamide/mesa and encephalopathy.
Cantwell BM; Harris AL
Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
[No Abstract] [Full Text] [Related]
10. Prediction of ifosfamide/mesna associated encephalopathy.
Meanwell CA; Blake AE; Kelly KA; Honigsberger L; Blackledge G
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):815-9. PubMed ID: 3095121
[TBL] [Abstract][Full Text] [Related]
11. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
Husband DJ; Watkin SW
Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
[No Abstract] [Full Text] [Related]
12. Ifosfamide/mesna encephalopathy.
McCallum AK
Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
[No Abstract] [Full Text] [Related]
13. Ifosfamide/mesna and hematuria.
Pratt CB; Goren MP
Cancer Treat Rep; 1987 Nov; 71(11):1124-5. PubMed ID: 3119210
[No Abstract] [Full Text] [Related]
14. Severe renal failure following high-dose ifosfamide and mesna.
Willemse PH; de Jong PE; Elema JD; Mulder NH
Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
Fosså SD; Talle K
Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide and mesna.
Schoenike SE; Dana WJ
Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide and Mesna in advanced malignancies.
Li GC; Brock N; Li JQ; Guan ZZ; He YJ
Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
[No Abstract] [Full Text] [Related]
18. Malignant pleural mesothelioma: phase II pilot study of ifosfamide and mesna.
Alberts AS; Falkson G; Van Zyl L
J Natl Cancer Inst; 1988 Jul; 80(9):698-700. PubMed ID: 3131539
[No Abstract] [Full Text] [Related]
19. Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
Hilgard P; Burkert H
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1451-2. PubMed ID: 6437825
[No Abstract] [Full Text] [Related]
20. Nursing implications in the administration of ifosfamide and mesna.
Richters JE
Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
